VeriMomБезопасен ли oligopeptide-106 при беременности?
No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
Related ingredients
Frequently asked questions
- Безопасен ли oligopeptide-106 при беременности?
- No harmonised CLP classification or SCCS/CIR safety assessment was identified for 'oligopeptide-106', and no peer‑reviewed reproductive toxicity or endocrine‑activity data are available in the major databases. Peptides used in cosmetics are generally high‑molecular‑weight and have low dermal absorption, so there is no evidence of a reproductive hazard under cosmetic use conditions (sources checked: ECHA Annex VI, SCCS/CIR listings, PubMed, CosIng, PubChem).
- Безопасен ли oligopeptide-106 при грудном вскармливании?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no mechanistic evidence for transfer into breast milk or effects on lactation were identified. Given the lack of adverse signals and expected low dermal/systemic absorption of cosmetic peptides, risk is not indicated for breastfeeding (sources checked: ECHA Annex VI, CIR, PubMed, CosIng, PubChem).
- Безопасен ли oligopeptide-106 для кожи малыша?
- No hazard or mechanistic data specific to infants were found. Adult dermal absorption is expected to be negligible for oligopeptides used in cosmetics (adult exposure scored 0), but because infant skin has a less mature barrier and higher surface‑area/weight, exposure scoring is increased by +1 to reflect potentially higher, low but measurable exposure in 0–3‑year‑olds. There is no infant‑specific toxicity evidence to increase hazard or mechanism scores (sources checked: CosIng, PubMed, ECHA Annex VI, PubChem).
- Как VeriMom оценивает oligopeptide-106?
- VeriMom оценивает oligopeptide-106 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы oligopeptide-106 при беременности?
- См. наш список безопасных альтернатив oligopeptide-106 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.